Intelligent Pills Market by Application, Target Area, Disease Indication Type, End-User, and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2030

10.53%
CAGR (2024-2030)
8.47 USD Bn.
Market Size
313
Report Pages
143
Market Tables

Overview

The Intelligent Pills Market size was valued at USD 8.47 Billion in 2023 and the total Intelligent Pills revenue is expected to grow at a CAGR of 10.53% from 2024 to 2030, reaching nearly USD 17.08 Billion.

Global Intelligent Pills Market Definition:

A smart pill is an ingestible medical device mainly available in a capsule sized vitamin pill and which in combination with a small electronic embedded product or appliances and drugs in it, such as patches, trackers, camera or sensors, sends wireless information about patients health parameters that help in monitoring and better diagnosis. Which, once swallowed, gets activated and offer non-invasive examination. Besides, smart pills have revolutionized the gastrointestinal diagnosis procedure and are likely to replace conventional diagnostic technique to give a potent alternative approach such as gastrointestinal endoscopy

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.Intelligent Pills MarketTo know about the Research Methodology :- Request Free Sample Report

Global Intelligent Pills Market Dynamics:

The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors involve the drivers, restraints, opportunities and challenges for the key companies and stakeholders in the industry.

The increasing need for minimally invasive devices, accurate therapeutic treatment strategies with increasing medication adherence, led to increasing demands for non-invasive diagnostic smart pills procedures, because of the fewer side-effects, ease of operation, better diagnostics of life-threatening medical conditions and various investment by many manufactures in R&D promotes improved drug portfolio. According to the report analysis, increasing medication and preference over conventional diagnostic devices for convenient and the small bowel diseases diagnosis will contribute to increasing demand for non-invasive drug therapy and smart pills which in turn will lead to market growth.

However, certain barriers such as high cost related with the ingestible sensors and stringent regulations concerning the increased use of technical devices, lack of knowledge and fear among patients about swallowing a microchip are few many factors estimated to restrain the market growth.

Global Intelligent Pills Market Opportunities:

Moreover, the increase in technological advances relating to smart pills such as micro-cameras, availability of microprocessors, bioelectronics, miniaturization, and others are expected to offer beneficial opportunities in future.

Key Developments in the Market:

In Jan 2021, PwC Australia at present aligned with TruTag and Colorcon to improve an innovative solution that inspires supply chain transparency in the pharmaceutical sector.

Global Intelligent Pills Market Market Segment Analysis:

The report covers competitive analysis of the Intelligent Pills Market in each of the geographical segments thereby providing insight into a market share at the macro as well as micro levels.

On the basis of application, capsule endoscopy segment is estimated to have more than half of total market share because of the innovation in technology advancement and growing acceptance of smart pills for GI disease diagnosis and treatment, such as small bowel disease diagnosis in intestine and colon cancer in which would register the highest CAGR of 13.6% because of the esophageal diseases and others research analysis and increasing occurrences of colon cancer.

In terms of End- User, hospital pharmacy is accounted to have more than half of total market share and is expected to continue its dominance over the forecast with the highest CAGR of 12.6% from 2024 to 2030, because of the increasing acceptance of capsule endoscopes in GI tract disorders diagnosis rate with increasing hospitalization using less time-consuming protocols, improved efficiencies with cost-efficient procedure and patient compliance.

Global Intelligent Pills Market Regional Insights

North America’s Intelligent Pills Market was valued at US$ 995 Mn in and is expected to reach a value of US$ 2215 Mn by , with a CAGR of 17.2%. North America is the largest market and accounted to dominate nearly half of the market with 57.1% share of which U.S, Canada contributes for major market because of the rapid acceptance of new endoscopic technologies, approvals by FDA, technological advancements, positive reimbursement scenario and increasing funding on investments by government and other companies in R&D for clinical trial as to potential growth also increasing cases of collateral cancer and for smart pills are many factors that will propel the market growth.

However, Asia-Pacific excluding japan registers the highest CAGR of 14% because of the high incidences to GI disorders and large investment for R&D by major agencies and government support and health insurance All these factors are responsible deliver the growth.

Competitive Analysis Global Intelligent Pills Market:

These market players in the Intelligent Pills Market have implemented various strategies such as partnerships, joint ventures, collaborations, expansions, new product launches and other crucial aspects to lessen the competition in the competitive landscape

Technavio is a leading global research company of North America in the U.S with US$ 212.97 million in smart pills during 2024-2030. Followed by Major manufacturers covered in the smart pills market are Chongqing Jinshan Science & Technology (Group) Co. Ltd., CapsoVision Inc., Intromedic Co. Ltd., Medtronic Plc, Olympus Corp., and Otsuka Holdings Co. Ltd.

Global Intelligent Pills Market Scope: Inquire before buying

Global Intelligent Pills Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: USD 8.47 Bn.
Forecast Period 2024 to 2030 CAGR: 10.53% Market Size in 2030: USD 17.08 Bn.
Segments Covered: by Application Capsule Endoscopy
Drug Delivery
Patient Monitoring
by Target Area Esophagus
Stomach
Small Intestine
Large Intestine
by Type Occult GI Bleeding
Chron’s disease
Small bowel tumors
Celiac disease
Inherited polyposis syndromes
Neurological disorder
Other disease indications
by End-User Hospital Pharmacy
Clinics
Research Institutes
Home Healthcare

Global Intelligent Pills Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)

Global Intelligent Pills Market, key Players

1. Medtronic, Inc.
2. Proteus Digital Health
3. CapsoVision, Inc.
4. Olympus Corporation
5. Medisafe
6. Medimetrics & Bio-Images Research
7. Given Imaging, Inc
8. Philips Healthcare.
9. Technavio
10. Boston Scientific Corporation
11. GE Healthcare
12. Keratin Biosciences, Inc.
13. Lloyds Pharmacy
14. Ostuka Holdings Co., Ltd.
15. 2Morrow Inc.
16. GINGER.IO,
17. PureTech Health,

Frequently Asked Questions:

1. Which region has the largest share in Global Intelligent Pills Market?
Ans: North America region held the highest share in 2023.

2. What is the growth rate of Global Intelligent Pills Market?
Ans: The Global Intelligent Pills Market is growing at a CAGR of 10.53% during forecasting period 2024-2030.

3. What is scope of the Global Intelligent Pills market report?
Ans: Global Intelligent Pills Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Intelligent Pills market?
Ans: The important key players in the Global Intelligent Pills Market are – Medtronic, Inc., Proteus Digital Health, CapsoVision, Inc., Olympus Corporation, Medisafe, Medimetrics & Bio-Images Research, Given Imaging, Inc, Philips Healthcare., Technavio, Boston Scientific Corporation, GE Healthcare, Keratin Biosciences, Inc., Lloyds Pharmacy, Ostuka Holdings Co., Ltd., 2Morrow Inc., GINGER.IO,, PureTech Health,, Livongo Health,, AliveCor, Inc.,, WellDoc, Inc.,, Volutis,, Omada Health, Inc

5. What was the Global Intelligent Pills Market size in 2023?
Ans: The Global Intelligent Pills Market size was USD 8.47 Billion in 2023.

Table of Contents

Global Intelligent Pills Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Intelligent Pills Market Size, by Market Value (US$ Bn) & Volume (Unit) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Intelligent Pills Market Analysis and Forecast 6.1. Global Intelligent Pills Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Intelligent Pills Market Analysis and Forecast, By Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Intelligent Pills Market Value Share Analysis, By Application 7.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By Application 7.5. Global Intelligent Pills Market Analysis, By Application 7.6. Global Intelligent Pills Market Attractiveness Analysis, By Application 8. Global Intelligent Pills Market Analysis and Forecast, By Target Area 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Intelligent Pills Market Value Share Analysis, By Target Area 8.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By Target Area 8.5. Global Intelligent Pills Market Analysis, By Target Area 8.6. Global Intelligent Pills Market Attractiveness Analysis, By Target Area 9. Global Intelligent Pills Market Analysis and Forecast, By Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Intelligent Pills Market Value Share Analysis, By Type 9.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By Type 9.5. Global Intelligent Pills Market Analysis, By Type 9.6. Global Intelligent Pills Market Attractiveness Analysis, By Type 10. Global Intelligent Pills Market Analysis and Forecast, By End user 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Intelligent Pills Market Value Share Analysis, By End user 10.4. Global Intelligent Pills Market Size (US$ Bn) Forecast, By End user 10.5. Global Intelligent Pills Market Analysis, By End user 10.6. Global Intelligent Pills Market Attractiveness Analysis, By End user 11. Global Intelligent Pills Market Analysis, by Region 11.1. Global Intelligent Pills Market Value Share Analysis, by Region 11.2. Global Intelligent Pills Market Size (US$ Bn) Forecast, by Region 11.3. Global Intelligent Pills Market Attractiveness Analysis, by Region 12. North America Intelligent Pills Market Analysis 12.1. Key Findings 12.2. North America Intelligent Pills Market Overview 12.3. North America Intelligent Pills Market Value Share Analysis, By Application 12.4. North America Intelligent Pills Market Forecast, By Application 12.4.1. Capsule Endoscopy 12.4.2. Drug Delivery 12.4.3. Patient Monitoring 12.5. North America Intelligent Pills Market Value Share Analysis, By Target Area 12.6. North America Intelligent Pills Market Forecast, By Target Area 12.6.1. Esophagus 12.6.2. Stomach 12.6.3. Small Intestine 12.6.4. Large Intestine 12.7. North America Intelligent Pills Market Value Share Analysis, By Type 12.8. North America Intelligent Pills Market Forecast, By Type 12.8.1. Occult GI Bleeding 12.8.2. Chron’s disease 12.8.3. Small bowel tumors 12.8.4. Celiac disease 12.8.5. Inherited polyposis syndromes 12.8.6. Neurological disorder 12.8.7. Other disease indications 12.9. North America Intelligent Pills Market Value Share Analysis, By End user 12.10. North America Intelligent Pills Market Forecast, By End user 12.10.1. Hospital Pharmacy 12.10.2. Clinics 12.10.3. Research Institutes 12.10.4. Home Healthcare 12.11. North America Intelligent Pills Market Value Share Analysis, by Country 12.12. North America Intelligent Pills Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Intelligent Pills Market Analysis, by Country 12.14. U.S. Intelligent Pills Market Forecast, By Application 12.14.1. Capsule Endoscopy 12.14.2. Drug Delivery 12.14.3. Patient Monitoring 12.15. U.S. Intelligent Pills Market Forecast, By Target Area 12.15.1. Esophagus 12.15.2. Stomach 12.15.3. Small Intestine 12.15.4. Large Intestine 12.16. U.S. Intelligent Pills Market Forecast, By Type 12.16.1. Occult GI Bleeding 12.16.2. Chron’s disease 12.16.3. Small bowel tumors 12.16.4. Celiac disease 12.16.5. Inherited polyposis syndromes 12.16.6. Neurological disorder 12.16.7. Other disease indications 12.17. U.S. Intelligent Pills Market Forecast, By End user 12.17.1. Hospital Pharmacy 12.17.2. Clinics 12.17.3. Research Institutes 12.17.4. Home Healthc 12.18. Canada Intelligent Pills Market Forecast, By Application 12.18.1. Capsule Endoscopy 12.18.2. Drug Delivery 12.18.3. Patient Monitoring 12.19. Canada Intelligent Pills Market Forecast, By Target Area 12.19.1. Esophagus 12.19.2. Stomach 12.19.3. Small Intestine 12.19.4. Large Intestine 12.20. Canada Intelligent Pills Market Forecast, By Type 12.20.1. Occult GI Bleeding 12.20.2. Chron’s disease 12.20.3. Small bowel tumors 12.20.4. Celiac disease 12.20.5. Inherited polyposis syndromes 12.20.6. Neurological disorder 12.20.7. Other disease indications 12.21. Canada Intelligent Pills Market Forecast, By End user 12.21.1. Hospital Pharmacy 12.21.2. Clinics 12.21.3. Research Institutes 12.21.4. Home Healthcare 12.22. North America Intelligent Pills Market Attractiveness Analysis 12.22.1. By Application 12.22.2. By Target Area 12.22.3. By Type 12.22.4. By End user 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Intelligent Pills Market Analysis 13.1. Key Findings 13.2. Europe Intelligent Pills Market Overview 13.3. Europe Intelligent Pills Market Value Share Analysis, By Application 13.4. Europe Intelligent Pills Market Forecast, By Application 13.4.1. Capsule Endoscopy 13.4.2. Drug Delivery 13.4.3. Patient Monitoring 13.5. Europe Intelligent Pills Market Value Share Analysis, By Target Area 13.6. Europe Intelligent Pills Market Forecast, By Target Area 13.6.1. Esophagus 13.6.2. Stomach 13.6.3. Small Intestine 13.6.4. Large Intestine 13.7. Europe Intelligent Pills Market Value Share Analysis, By Type 13.8. Europe Intelligent Pills Market Forecast, By Type 13.8.1. Occult GI Bleeding 13.8.2. Chron’s disease 13.8.3. Small bowel tumors 13.8.4. Celiac disease 13.8.5. Inherited polyposis syndromes 13.8.6. Neurological disorder 13.8.7. Other disease indications 13.9. Europe Intelligent Pills Market Value Share Analysis, By End user 13.10. Europe Intelligent Pills Market Forecast, By End user 13.10.1. Hospital Pharmacy 13.10.2. Clinics 13.10.3. Research Institutes 13.10.4. Home Healthcare 13.11. Europe Intelligent Pills Market Value Share Analysis, by Country 13.12. Europe Intelligent Pills Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Intelligent Pills Market Analysis, by Country 13.14. Germany Intelligent Pills Market Forecast, By Application 13.14.1. Capsule Endoscopy 13.14.2. Drug Delivery 13.14.3. Patient Monitoring 13.15. Germany Intelligent Pills Market Forecast, By Target Area 13.15.1. Esophagus 13.15.2. Stomach 13.15.3. Small Intestine 13.15.4. Large Intestine 13.16. Germany Intelligent Pills Market Forecast, By Type 13.16.1. Occult GI Bleeding 13.16.2. Chron’s disease 13.16.3. Small bowel tumors 13.16.4. Celiac disease 13.16.5. Inherited polyposis syndromes 13.16.6. Neurological disorder 13.16.7. Other disease indications 13.17. Germany Intelligent Pills Market Forecast, By End user 13.17.1. Hospital Pharmacy 13.17.2. Clinics 13.17.3. Research Institutes 13.17.4. Home Healthcare 13.18. U.K. Intelligent Pills Market Forecast, By Application 13.18.1. Capsule Endoscopy 13.18.2. Drug Delivery 13.18.3. Patient Monitoring 13.19. U.K. Intelligent Pills Market Forecast, By Target Area 13.19.1. Esophagus 13.19.2. Stomach 13.19.3. Small Intestine 13.19.4. Large Intestine 13.20. U.K. Intelligent Pills Market Forecast, By Type 13.20.1. Occult GI Bleeding 13.20.2. Chron’s disease 13.20.3. Small bowel tumors 13.20.4. Celiac disease 13.20.5. Inherited polyposis syndromes 13.20.6. Neurological disorder 13.20.7. Other disease indications 13.21. U.K. Intelligent Pills Market Forecast, By End user 13.21.1. Hospital Pharmacy 13.21.2. Clinics 13.21.3. Research Institutes 13.21.4. Home Healthcare 13.22. France Intelligent Pills Market Forecast, By Application 13.22.1. Capsule Endoscopy 13.22.2. Drug Delivery 13.22.3. Patient Monitoring 13.23. France Intelligent Pills Market Forecast, By Target Area 13.23.1. Esophagus 13.23.2. Stomach 13.23.3. Small Intestine 13.23.4. Large Intestine 13.24. France Intelligent Pills Market Forecast, By Type 13.24.1. Occult GI Bleeding 13.24.2. Chron’s disease 13.24.3. Small bowel tumors 13.24.4. Celiac disease 13.24.5. Inherited polyposis syndromes 13.24.6. Neurological disorder 13.24.7. Other disease indications 13.25. France Intelligent Pills Market Forecast, By End user 13.25.1. Hospital Pharmacy 13.25.2. Clinics 13.25.3. Research Institutes 13.25.4. Home Healthcare 13.26. Italy Intelligent Pills Market Forecast, By Application 13.26.1. Capsule Endoscopy 13.26.2. Drug Delivery 13.26.3. Patient Monitoring 13.27. Italy Intelligent Pills Market Forecast, By Target Area 13.27.1. Esophagus 13.27.2. Stomach 13.27.3. Small Intestine 13.27.4. Large Intestine 13.28. Italy Intelligent Pills Market Forecast, By Type 13.28.1. Occult GI Bleeding 13.28.2. Chron’s disease 13.28.3. Small bowel tumors 13.28.4. Celiac disease 13.28.5. Inherited polyposis syndromes 13.28.6. Neurological disorder 13.28.7. Other disease indications 13.29. Italy Intelligent Pills Market Forecast, By End user 13.29.1. Hospital Pharmacy 13.29.2. Clinics 13.29.3. Research Institutes 13.29.4. Home Healthcare 13.30. Spain Intelligent Pills Market Forecast, By Application 13.30.1. Capsule Endoscopy 13.30.2. Drug Delivery 13.30.3. Patient Monitoring 13.31. Spain Intelligent Pills Market Forecast, By Target Area 13.31.1. Esophagus 13.31.2. Stomach 13.31.3. Small Intestine 13.31.4. Large Intestine 13.32. Spain Intelligent Pills Market Forecast, By Type 13.32.1. Occult GI Bleeding 13.32.2. Chron’s disease 13.32.3. Small bowel tumors 13.32.4. Celiac disease 13.32.5. Inherited polyposis syndromes 13.32.6. Neurological disorder 13.32.7. Other disease indications 13.33. Spain Intelligent Pills Market Forecast, By End user 13.33.1. Hospital Pharmacy 13.33.2. Clinics 13.33.3. Research Institutes 13.33.4. Home Healthcare 13.34. Rest of Europe Intelligent Pills Market Forecast, By Application 13.34.1. Capsule Endoscopy 13.34.2. Drug Delivery 13.34.3. Patient Monitoring 13.35. Rest of Europe Intelligent Pills Market Forecast, By Target Area 13.35.1. Esophagus 13.35.2. Stomach 13.35.3. Small Intestine 13.35.4. Large Intestine 13.36. Rest of Europe Intelligent Pills Market Forecast, By Type 13.36.1. Occult GI Bleeding 13.36.2. Chron’s disease 13.36.3. Small bowel tumors 13.36.4. Celiac disease 13.36.5. Inherited polyposis syndromes 13.36.6. Neurological disorder 13.36.7. Other disease indications 13.37. Rest Of Europe Intelligent Pills Market Forecast, By End user 13.37.1. Hospital Pharmacy 13.37.2. Clinics 13.37.3. Research Institutes 13.37.4. Home Healthcare 13.38. Europe Intelligent Pills Market Attractiveness Analysis 13.38.1. By Application 13.38.2. By Target Area 13.38.3. By Type 13.38.4. By End user 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Intelligent Pills Market Analysis 14.1. Key Findings 14.2. Asia Pacific Intelligent Pills Market Overview 14.3. Asia Pacific Intelligent Pills Market Value Share Analysis, By Application 14.4. Asia Pacific Intelligent Pills Market Forecast, By Application 14.4.1. Capsule Endoscopy 14.4.2. Drug Delivery 14.4.3. Patient Monitoring 14.5. Asia Pacific Intelligent Pills Market Value Share Analysis, By Target Area 14.6. Asia Pacific Intelligent Pills Market Forecast, By Target Area 14.6.1. Esophagus 14.6.2. Stomach 14.6.3. Small Intestine 14.6.4. Large Intestine 14.7. Asia Pacific Intelligent Pills Market Value Share Analysis, By Type 14.8. Asia Pacific Intelligent Pills Market Forecast, By Type 14.8.1. Occult GI Bleeding 14.8.2. Chron’s disease 14.8.3. Small bowel tumors 14.8.4. Celiac disease 14.8.5. Inherited polyposis syndromes 14.8.6. Neurological disorder 14.8.7. Other disease indications 14.9. Asia Pacific Intelligent Pills Market Value Share Analysis, By End user 14.10. Asia Pacific Intelligent Pills Market Forecast, By End user 14.10.1. Hospital Pharmacy 14.10.2. Clinics 14.10.3. Research Institutes 14.10.4. Home Healthcare 14.11. Asia Pacific Intelligent Pills Market Value Share Analysis, by Country 14.12. Asia Pacific Intelligent Pills Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Intelligent Pills Market Analysis, by Country 14.14. China Intelligent Pills Market Forecast, By Application 14.14.1. Capsule Endoscopy 14.14.2. Drug Delivery 14.14.3. Patient Monitoring 14.15. China Intelligent Pills Market Forecast, By Target Area 14.15.1. Esophagus 14.15.2. Stomach 14.15.3. Small Intestine 14.15.4. Large Intestine 14.16. China Intelligent Pills Market Forecast, By Type 14.16.1. Occult GI Bleeding 14.16.2. Chron’s disease 14.16.3. Small bowel tumors 14.16.4. Celiac disease 14.16.5. Inherited polyposis syndromes 14.16.6. Neurological disorder 14.16.7. Other disease indications 14.17. China Intelligent Pills Market Forecast, By End user 14.17.1. Hospital Pharmacy 14.17.2. Clinics 14.17.3. Research Institutes 14.17.4. Home Healthcare 14.18. India Intelligent Pills Market Forecast, By Application 14.18.1. Capsule Endoscopy 14.18.2. Drug Delivery 14.18.3. Patient Monitoring 14.19. India Intelligent Pills Market Forecast, By Target Area 14.19.1. Esophagus 14.19.2. Stomach 14.19.3. Small Intestine 14.19.4. Large Intestine 14.20. India Intelligent Pills Market Forecast, By Type 14.20.1. Occult GI Bleeding 14.20.2. Chron’s disease 14.20.3. Small bowel tumors 14.20.4. Celiac disease 14.20.5. Inherited polyposis syndromes 14.20.6. Neurological disorder 14.20.7. Other disease indications 14.21. India Intelligent Pills Market Forecast, By End user 14.21.1. Hospital Pharmacy 14.21.2. Clinics 14.21.3. Research Institutes 14.21.4. Home Healthcare 14.22. Japan Intelligent Pills Market Forecast, By Application 14.22.1. Capsule Endoscopy 14.22.2. Drug Delivery 14.22.3. Patient Monitoring 14.23. Japan Intelligent Pills Market Forecast, By Target Area 14.23.1. Esophagus 14.23.2. Stomach 14.23.3. Small Intestine 14.23.4. Large Intestine 14.24. Japan Intelligent Pills Market Forecast, By Type 14.24.1. Occult GI Bleeding 14.24.2. Chron’s disease 14.24.3. Small bowel tumors 14.24.4. Celiac disease 14.24.5. Inherited polyposis syndromes 14.24.6. Neurological disorder 14.24.7. Other disease indications 14.25. Japan Intelligent Pills Market Forecast, By End user 14.25.1. Hospital Pharmacy 14.25.2. Clinics 14.25.3. Research Institutes 14.25.4. Home Healthcare 14.26. ASEAN Intelligent Pills Market Forecast, By Application 14.26.1. Capsule Endoscopy 14.26.2. Drug Delivery 14.26.3. Patient Monitoring 14.27. ASEAN Intelligent Pills Market Forecast, By Target Area 14.27.1. Esophagus 14.27.2. Stomach 14.27.3. Small Intestine 14.27.4. Large Intestine 14.28. ASEAN Intelligent Pills Market Forecast, By Type 14.28.1. Occult GI Bleeding 14.28.2. Chron’s disease 14.28.3. Small bowel tumors 14.28.4. Celiac disease 14.28.5. Inherited polyposis syndromes 14.28.6. Neurological disorder 14.28.7. Other disease indications 14.29. ASEAN Intelligent Pills Market Forecast, By End user 14.29.1. Hospital Pharmacy 14.29.2. Clinics 14.29.3. Research Institutes 14.29.4. Home Healthcare 14.30. Rest of Asia Pacific Intelligent Pills Market Forecast, By Application 14.30.1. Capsule Endoscopy 14.30.2. Drug Delivery 14.30.3. Patient Monitoring 14.31. Rest of Asia Pacific Intelligent Pills Market Forecast, By Target Area 14.31.1. Esophagus 14.31.2. Stomach 14.31.3. Small Intestine 14.31.4. Large Intestine 14.32. Rest of Asia Pacific Intelligent Pills Market Forecast, By Type 14.32.1. Occult GI Bleeding 14.32.2. Chron’s disease 14.32.3. Small bowel tumors 14.32.4. Celiac disease 14.32.5. Inherited polyposis syndromes 14.32.6. Neurological disorder 14.32.7. Other disease indications 14.33. Rest of Asia Pacific Intelligent Pills Market Forecast, By End user 14.33.1. Hospital Pharmacy 14.33.2. Clinics 14.33.3. Research Institutes 14.33.4. Home Healthcare 14.34. Asia Pacific Intelligent Pills Market Attractiveness Analysis 14.34.1. By Application 14.34.2. By Target Area 14.34.3. By Type 14.34.4. By End user 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Intelligent Pills Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Intelligent Pills Market Overview 15.3. Middle East & Africa Intelligent Pills Market Value Share Analysis, By Application 15.4. Middle East & Africa Intelligent Pills Market Forecast, By Application 15.4.1. Capsule Endoscopy 15.4.2. Drug Delivery 15.4.3. Patient Monitoring 15.5. Middle East & Africa Intelligent Pills Market Value Share Analysis, By Target Area 15.6. Middle East & Africa Intelligent Pills Market Forecast, By Target Area 15.6.1. Esophagus 15.6.2. Stomach 15.6.3. Small Intestine 15.6.4. Large Intestine 15.7. Middle East & Africa Intelligent Pills Market Value Share Analysis, By Type 15.8. Middle East & Africa Intelligent Pills Market Forecast, By Type 15.8.1. Occult GI Bleeding 15.8.2. Chron’s disease 15.8.3. Small bowel tumors 15.8.4. Celiac disease 15.8.5. Inherited polyposis syndromes 15.8.6. Neurological disorder 15.8.7. Other disease indications 15.9. Middle East & Africa Intelligent Pills Market Value Share Analysis, By End user 15.10. Middle East & Africa Intelligent Pills Market Forecast, By End user 15.10.1. Hospital Pharmacy 15.10.2. Clinics 15.10.3. Research Institutes 15.10.4. Home Healthcare 15.11. Middle East & Africa Intelligent Pills Market Value Share Analysis, by Country 15.12. Middle East & Africa Intelligent Pills Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Intelligent Pills Market Analysis, by Country 15.14. GCC Intelligent Pills Market Forecast, By Application 15.14.1. Capsule Endoscopy 15.14.2. Drug Delivery 15.14.3. Patient Monitoring 15.15. GCC Intelligent Pills Market Forecast, By Target Area 15.15.1. Esophagus 15.15.2. Stomach 15.15.3. Small Intestine 15.15.4. Large Intestine 15.16. GCC Intelligent Pills Market Forecast, By Type 15.16.1. Occult GI Bleeding 15.16.2. Chron’s disease 15.16.3. Small bowel tumors 15.16.4. Celiac disease 15.16.5. Inherited polyposis syndromes 15.16.6. Neurological disorder 15.16.7. Other disease indications 15.17. GCC Intelligent Pills Market Forecast, By End user 15.17.1. Hospital Pharmacy 15.17.2. Clinics 15.17.3. Research Institutes 15.17.4. Home Healthcare 15.18. South Africa Intelligent Pills Market Forecast, By Application 15.18.1. Capsule Endoscopy 15.18.2. Drug Delivery 15.18.3. Patient Monitoring 15.19. South Africa Intelligent Pills Market Forecast, By Target Area 15.19.1. Esophagus 15.19.2. Stomach 15.19.3. Small Intestine 15.19.4. Large Intestine 15.20. South Africa Intelligent Pills Market Forecast, By Type 15.20.1. Occult GI Bleeding 15.20.2. Chron’s disease 15.20.3. Small bowel tumors 15.20.4. Celiac disease 15.20.5. Inherited polyposis syndromes 15.20.6. Neurological disorder 15.20.7. Other disease indications 15.21. South Africa Intelligent Pills Market Forecast, By End user 15.21.1. Hospital Pharmacy 15.21.2. Clinics 15.21.3. Research Institutes 15.21.4. Home Healthcare 15.22. Rest of Middle East & Africa Intelligent Pills Market Forecast, By Application 15.22.1. Capsule Endoscopy 15.22.2. Drug Delivery 15.22.3. Patient Monitoring 15.23. Rest of Middle East & Africa Intelligent Pills Market Forecast, By Target Area 15.23.1. Esophagus 15.23.2. Stomach 15.23.3. Small Intestine 15.23.4. Large Intestine 15.24. Rest of Middle East & Africa Intelligent Pills Market Forecast, By Type 15.24.1. Occult GI Bleeding 15.24.2. Chron’s disease 15.24.3. Small bowel tumors 15.24.4. Celiac disease 15.24.5. Inherited polyposis syndromes 15.24.6. Neurological disorder 15.24.7. Other disease indications 15.25. Rest of Middle East & Africa Intelligent Pills Market Forecast, By End user 15.25.1. Hospital Pharmacy 15.25.2. Clinics 15.25.3. Research Institutes 15.25.4. Home Healthcare 15.26. Middle East & Africa Intelligent Pills Market Attractiveness Analysis 15.26.1. By Application 15.26.2. By Target Area 15.26.3. By Type 15.26.4. By End user 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Intelligent Pills Market Analysis 16.1. Key Findings 16.2. South America Intelligent Pills Market Overview 16.3. South America Intelligent Pills Market Value Share Analysis, By Application 16.4. South America Intelligent Pills Market Forecast, By Application 16.4.1. Capsule Endoscopy 16.4.2. Drug Delivery 16.4.3. Patient Monitoring 16.5. South America Intelligent Pills Market Value Share Analysis, By Target Area 16.6. South America Intelligent Pills Market Forecast, By Target Area 16.6.1. Esophagus 16.6.2. Stomach 16.6.3. Small Intestine 16.6.4. Large Intestine 16.7. South America Intelligent Pills Market Value Share Analysis, By Type 16.8. South America Intelligent Pills Market Forecast, By Type 16.8.1. Occult GI Bleeding 16.8.2. Chron’s disease 16.8.3. Small bowel tumors 16.8.4. Celiac disease 16.8.5. Inherited polyposis syndromes 16.8.6. Neurological disorder 16.8.7. Other disease indications 16.9. South America Intelligent Pills Market Value Share Analysis, By End user 16.10. South America Intelligent Pills Market Forecast, By End user 16.10.1. Hospital Pharmacy 16.10.2. Clinics 16.10.3. Research Institutes 16.10.4. Home Healthcare 16.11. South America Intelligent Pills Market Value Share Analysis, by Country 16.12. South America Intelligent Pills Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Intelligent Pills Market Analysis, by Country 16.14. Brazil Intelligent Pills Market Forecast, By Application 16.14.1. Capsule Endoscopy 16.14.2. Drug Delivery 16.14.3. Patient Monitoring 16.15. Brazil Intelligent Pills Market Forecast, By Target Area 16.15.1. Esophagus 16.15.2. Stomach 16.15.3. Small Intestine 16.15.4. Large Intestine 16.16. Brazil Intelligent Pills Market Forecast, By Type 16.16.1. Occult GI Bleeding 16.16.2. Chron’s disease 16.16.3. Small bowel tumors 16.16.4. Celiac disease 16.16.5. Inherited polyposis syndromes 16.16.6. Neurological disorder 16.16.7. Other disease indications 16.17. Brazil Intelligent Pills Market Forecast, By End user 16.17.1. Hospital Pharmacy 16.17.2. Clinics 16.17.3. Research Institutes 16.17.4. Home Healthcare 16.18. Mexico Intelligent Pills Market Forecast, By Application 16.18.1. Capsule Endoscopy 16.18.2. Drug Delivery 16.18.3. Patient Monitoring 16.19. Mexico Intelligent Pills Market Forecast, By Target Area 16.19.1. Esophagus 16.19.2. Stomach 16.19.3. Small Intestine 16.19.4. Large Intestine 16.20. Mexico Intelligent Pills Market Forecast, By Type 16.20.1. Occult GI Bleeding 16.20.2. Chron’s disease 16.20.3. Small bowel tumors 16.20.4. Celiac disease 16.20.5. Inherited polyposis syndromes 16.20.6. Neurological disorder 16.20.7. Other disease indications 16.21. Mexico Intelligent Pills Market Forecast, By End user 16.21.1. Hospital Pharmacy 16.21.2. Clinics 16.21.3. Research Institutes 16.21.4. Home Healthcare 16.22. Rest of South America Intelligent Pills Market Forecast, By Application 16.22.1. Capsule Endoscopy 16.22.2. Drug Delivery 16.22.3. Patient Monitoring 16.23. Rest of South America Intelligent Pills Market Forecast, By Target Area 16.23.1. Esophagus 16.23.2. Stomach 16.23.3. Small Intestine 16.23.4. Large Intestine 16.24. Rest of South America Intelligent Pills Market Forecast, By Type 16.24.1. Occult GI Bleeding 16.24.2. Chron’s disease 16.24.3. Small bowel tumors 16.24.4. Celiac disease 16.24.5. Inherited polyposis syndromes 16.24.6. Neurological disorder 16.24.7. Other disease indications 16.25. Rest of South America Intelligent Pills Market Forecast, By End user 16.25.1. Hospital Pharmacy 16.25.2. Clinics 16.25.3. Research Institutes 16.25.4. Home Healthcare 16.26. South America Intelligent Pills Market Attractiveness Analysis 16.26.1. By Application 16.26.2. By Target Area 16.26.3. By Type 16.26.4. By End user 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.1. Company Profiles: Key Players 17.1.1. Bayer 17.1.1.1. Company Overview 17.1.1.2. Financial Overview 17.1.1.3. Product Portfolio 17.1.1.4. Business Strategy 17.1.1.5. Recent Developments 17.1.1.6. Development Footprint 17.1.2. Biogen 17.1.3. Merck KGaA 17.1.4. Teva 17.1.5. Sanofi 17.1.6. Novartis 17.1.7. Roche 17.1.8. Acorda Therapeutics, Inc. 17.1.9. EMD Serono (Merck KGaA) 17.1.10. AbbVie, Inc 17.1.11. Actelion 17.1.12. Celgene 17.1.13. AbbVie 17.1.14. Alkermes 17.1.15. TG Therapeutics 17.1.16. GeNeuro 17.1.17. Antisense Therapeutics 17.1.18. AB Science 17.1.19. MedDay 17.1.20. Coherus Bioscience 17.1.21. InnoBioscience 17.1.22. MediciNova 17.1.23. Santhera Pharmaceuticals 17.1.24. GSK 17.1.25. Ionis Pharmaceutical 18. Primary Key Insights